Jounce Therapeutics

Closed

Daring to create a world immune to cancer.

Jounce Therapeutics was founded in 2013, is headquartered in Cambridge, United States, lists 51–200 employees, and has $56.0M in recorded funding across 2 rounds.

Headquarters
Cambridge
Employees
51–200
Founded
2013
Business Model
B2B
Total Funding
$56.0M
Last Round
$56.0M Series BApr 2015
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable a patient's immune system to combat tumors. Founded in 2013 by world leaders in immunobiology, cancer biology, and clinical and translational medicine, including Richard Murray, Gordon Freeman, and Glenn Dranoff, the company launched with backing from Third Rock Ventures. Jounce's research is grounded in translational science that identifies patient subsets most likely to respond to immunotherapy combinations.

Summary

Jounce Therapeutics is a Biotech company based in Cambridge, United States, founded in 2013. It lists 51–200 employees. It has raised $56.0M in total across 2 rounds, most recently a $56.0M Series B round in Apr 2015. Investors include Casdin Capital, Fidelity Management and Foresite Capital.

Funding & Exit History

IPO2017 (est.)

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Jounce Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/jounce-therapeutics"><img src="https://indexed.vc/api/badge/company/jounce-therapeutics" alt="Jounce Therapeutics on Indexed.vc" width="260" height="76" /></a>